General Trial findings do not support prasugrel monotherapy at the time of primary PCI for STEMI patientsBy Healthcare Propulsion StaffAugust 29, 20260 Monotherapy using prasugrel failed to show noninferiority compared with potent antiplatelet therapy plus aspirin at the time of primary percutaneous…
General SWITCH SWEDEHEART trial shows prasugrel matches ticagrelor with less bleedingBy Healthcare Propulsion StaffAugust 29, 20260 Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in…
